Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Number of FDA approvals for new molecular entities in 1999-2001 and 2009-2011

Number of FDA approvals for new molecular entities in the periods 1999-2001 and 2009-2011

by Statista Research Department, last edited Jul 1, 2013
Number of FDA approvals for new molecular entities in 1999-2001 and 2009-2011 This statistic depicts the number of FDA approvals for new molecular entities in the periods 1999-2001 and 2009-2011. In the United States, the number of approvals in dermatology and respiratory areas both dropped from three approvals in 1999-2001 to just one in 2009-2011.
Show more

Number of FDA approvals for new molecular entities in the periods 1999-2001 and 2009-2011

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Canadian pharmaceutical industry"
  • Global positioning
The most important statistics
  • Key figures
  • Regional comparison
  • Generics
  • Products and prices
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.